[Hemorrhage treatment: Evaluation of the proper use of fibrinogen concentrate]

Jennifer Howlett1, Christelle Prudent1, Emmanuel De Maistre2

  • 1Service pharmacie, hôpital François-Mitterrand, 14, rue Gaffarel, 21000 Dijon, France.

Therapie
|March 25, 2017
PubMed

Insights

Fibrinogen concentrate prescriptions increased after 2015 guidelines. Evaluation showed appropriate dosing in 73% of cases, but low fibrinogen levels were below recommended limits in 59%, questioning prescription necessity.

Area of Science:

  • Hematology
  • Clinical Pharmacy
  • Medical Guidelines

Background:

  • Fibrinogen concentrate prescriptions rose significantly in 2015 following new guideline publications.
  • The study addresses the need to assess the appropriate utilization of fibrinogen concentrate post-guideline implementation.

Purpose of the Study:

  • To evaluate the conformity of fibrinogen concentrate prescriptions with established clinical guidelines.
  • To assess the appropriateness of prescribed dosages and patient outcomes.

Main Methods:

  • Retrospective analysis of 202 prescriptions for 117 patients.
  • Evaluation criteria included fibrinogen level measurement, adherence to recommended dosage thresholds, and posology conformity.
  • Assessment of treatment efficacy and safety was also performed.

Main Results:

  • Indications for prescription were met in all but one case.
  • Blood fibrinogen levels were measured in 76% of prescriptions, with 59% below the recommended threshold for prescription.
  • Prescription posology aligned with guidelines in 73% of cases; 20% were underdosed.
  • Patients receiving lower doses appeared to have lower risk, raising questions about prescription necessity.

Conclusions:

  • Guideline adherence for fibrinogen concentrate prescription varies, influenced by the urgency of the clinical situation.
  • Further prospective studies are recommended to elucidate the reasons for prescribing doses below guideline recommendations.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.7K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
428
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
331
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
15.5K
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.4K